Selçuk Yaylaci

Institution. Sakarya University Faculty of Medicine
AddressSakarya
Turkey
vCardDownload vCard
    Publication Timeline
    COVID-19 publications
    Bar chart showing 23 Covid-19 publications, with a maximum of 6 publications in Spetember 2020
    All Publications
    Bar chart showing 36 publications over 7 distinct years, with a maximum of 12 publications in 2021
    These graphs show COVID-19 publications by month since August 2019 and all publications written by authors of COVID-19 publications over the past 30 years.

    To see the data from both graphs as text, click here.
    Publication Field Summary
    This graph shows the number and percent of publications by field. Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications. Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written. To see the data as text, click here.
    Publication List
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications.
    Sort By:     Newest   |   Oldest   |   Most Cited   |   Most Discussed
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Dheir H, Karacan A, Sipahi S, Yaylaci S, Tocoglu A, Demirci T, Cetin ES, Guneysu F, Firat N, Varim C, Karabay O. Correlation between venous blood gas indices and radiological involvements of COVID-19 patients at first admission to emergency department. Rev Assoc Med Bras (1992). 2021; 67Suppl 1(Suppl 1):51-56. PMID: 34406295.
      Citations:    Fields:    Translation:Humans
    2. Ozdin M, Cokluk E, Yaylaci S, Koroglu M, Genc AC, Cekic D, Aydemir Y, Karacan A, Erdem AF, Karabay O. Evaluation of coagulation parameters: Coronavirus disease 2019 (COVID-19) between survivors and nonsurvivors. Rev Assoc Med Bras (1992). 2021; 67Suppl 1(Suppl 1):74-79. PMID: 34406297.
      Citations:    Fields:    Translation:Humans
    3. Ozdin M, Yazar H, Yaylaci S, Koroglu M, Genc AC, Kocayigit I, Genc AB, Yildirim I, Kocayigit H, Karabay O. Evaluation of cardiac parameters between survivors and nonsurvivors of COVID-19 patients. Rev Assoc Med Bras (1992). 2021; 67Suppl 1(Suppl 1):80-85. PMID: 34406298.
      Citations:    Fields:    Translation:Humans
    4. Nalbant A, Aydin A, Yaylaci S, Kaya T, Wermeulen CL, Cinemre H. Association of ABO blood group and age with COVID-19 positive test. Rev Assoc Med Bras (1992). 2021; 67Suppl 1(Suppl 1):46-50. PMID: 34259764.
      Citations:    Fields:    Translation:Humans
    5. Issever K, Genc AC, Cekic D, Yildirim I, Genc AB, Yaylaci S. Prealbumin: A New Biomarker for Predicting Prognosis in Patients with Severe COVID-19. J Coll Physicians Surg Pak. 2021 07; 31(7):S99-S103. PMID: 34271804.
      Citations:    Fields:    Translation:Humans
    6. Aydemir Y, Gündüz Y, Köroglu M, Karabay O, Dheir H, Sengül A, Yaylaci S, Kocayigit H, Erdem AF, Aydemir Ö, Güçlü E, Yürümez Y. The relationship of extent of initial radiological involvement with the need of intensive care, mortality rates, and laboratory parameters in Covid-19 Turk J Med Sci. 2021 06 28; 51(3):1012-1020. PMID: 33705639.
      Citations: 1     Fields:    Translation:HumansPHPublic Health
    7. Kocayigit H, Özmen Süner K, Tomak Y, Demir G, Kocayigit I, Yaylaci S, Aydemir Y, Köroglu M, Karabay O, Öztürk MH, Erdem AF. Characteristics and outcomes of critically ill patients with covid-19 in Sakarya, Turkey: a single centre cohort study Turk J Med Sci. 2021 04 30; 51(2):440-447. PMID: 33185365.
      Citations: 5     Fields:    Translation:Humans
    8. Dheir H, Sipahi S, Yaylaci S, Çetin ES, Genç AB, Firat N, Köroglu M, Muratdagi G, Tomak Y, Özmen K, Ates ÖF, Karabay O. Clinical course of COVID-19 disease in immunosuppressed renal transplant patients Turk J Med Sci. 2021 04 30; 51(2):428-434. PMID: 33185367.
      Citations: 1     Fields:    Translation:Humans
    9. Genç AB, Yaylaci S, Dheir H, Genç AC, Issever K, Çekiç D, Kocayigit H, Çokluk E, Karacan A, Sekeroglu MR, Toptan Çakar H, Güçlü E. The predictive and diagnostic accuracy of long pentraxin-3 in COVID-19 pneumonia Turk J Med Sci. 2021 04 30; 51(2):448-453. PMID: 33315349.
      Citations: 2     Fields:    Translation:Humans
    10. Kocayigit H, Demir G, Karacan A, Süner KÖ, Tomak Y, Yaylaci S, Dheir H, Kalpakci Y, Erdem AF. Effects on mortality of early vs late administration of convalescent plasma in the treatment of Covid-19. Transfus Apher Sci. 2021 Aug; 60(4):103148. PMID: 33962885.
      Citations:    Fields:    Translation:HumansPHPublic Health
    11. Dheir H, Yaylaci S, Sipahi S, Genc AC, Cekic D, Tuncer FB, Cokluk E, Kocayigit H, Genc AB, Salihi S, Varim C, Karabay O. Does Macrophage Migration Inhibitory Factor predict the prognosis of COVID-19 disease? J Infect Dev Ctries. 2021 Mar 31; 15(3):398-403. PMID: 33839715.
      Citations:    Fields:    Translation:Humans
    12. Kaya T, Yaylaci S, Nalbant A, Yildirim I, Kocayigit H, Çokluk E, Sekeroglu MR, Köroglu M, Güçlü E. Serum calprotectin as a novel biomarker for severity of COVID-19 disease. Ir J Med Sci. 2022 Feb; 191(1):59-64. PMID: 33641087.
      Citations: 3     Fields:    
    13. Kocayigit H, Özmen Süner K, Tomak Y, Demir G, Yaylaci S, Dheir H, Güçlü E, Erdem AF. Observational study of the effects of Favipiravir vs Lopinavir/Ritonavir on clinical outcomes in critically Ill patients with COVID-19. J Clin Pharm Ther. 2021 Apr; 46(2):454-459. PMID: 33128482.
      Citations: 6     Fields:    Translation:Humans
    14. Karacaer C, Karabay O, Gunduz Y, Yaylaci S, Guclu E. Correlation of Lung Ultrasound and Computed Tomography Findings in COVID-19 Pneumonia. J Coll Physicians Surg Pak. 2020 Oct; 30(10):147-152. PMID: 33291193.
      Citations:    Fields:    Translation:HumansPHPublic Health
    15. Yaylaci S, Dheir H, Senocak D, Genc AB, Kocayigit H, Çekiç D, Varim C, Aydin A, Koroglu M, Karabay O. The effects of favipiravir on hematological parameters of covid-19 patients. Rev Assoc Med Bras (1992). 2020; 66Suppl 2(Suppl 2):65-70. PMID: 32965359.
      Citations: 1     Fields:    Translation:HumansCellsPHPublic Health
    16. Kocayigit I, Kocayigit H, Yaylaci S, Can Y, Erdem AF, Karabay O. Impact of antihypertensive agents on clinical course and in-hospital mortality: analysis of 169 hypertensive patients hospitalized for COVID-19. Rev Assoc Med Bras (1992). 2020; 66Suppl 2(Suppl 2):71-76. PMID: 32965360.
      Citations: 4     Fields:    Translation:HumansCellsPHPublic Health
    17. Varim C, Yaylaci S, Demirci T, Kaya T, Nalbant A, Dheir H, Senocak D, Kurt R, Cengiz H, Karacaer C. Neutrophil count to albumin ratio as a new predictor of mortality in patients with COVID-19 infection. Rev Assoc Med Bras (1992). 2020; 66Suppl 2(Suppl 2):77-81. PMID: 32965361.
      Citations: 4     Fields:    Translation:HumansCellsPHPublic Health
    18. Yaylaci S, Dheir H, Issever K, Genc AB, Senocak D, Kocayigit H, Guclu E, Suner K, Ekerbicer H, Koroglu M. The effect of abo and rh blood group antigens on admission to intensive care unit and mortality in patients with COVID-19 infection. Rev Assoc Med Bras (1992). 2020; 66Suppl 2(Suppl 2):86-90. PMID: 32965363.
      Citations: 6     Fields:    Translation:HumansCellsPHPublic Health
    19. Karabay O, Köse O, Tocoglu A, Uysal B, Dheir H, Yaylaci S, Guclu E. Investigation of the frequency of COVID-19 in patients treated with intravesical BCG. Rev Assoc Med Bras (1992). 2020; 66Suppl 2(Suppl 2):91-95. PMID: 32965364.
      Citations: 2     Fields:    Translation:HumansCellsPHPublic Health
    20. Dheir H, Sipahi S, Yaylaci S, Genc AC, Genc FT, Genc AB, Guçlu E, Muratdagi G, Toptan H, Karabay O. Is the COVID-19 disease associated with de novo nephritic syndrome? Rev Assoc Med Bras (1992). 2020 Sep; 66(9):1258-1263. PMID: 33027455.
      Citations: 1     Fields:    Translation:HumansCellsPHPublic Health
    21. Güçlü E, Kocayigit H, Okan HD, Erkorkmaz U, Yürümez Y, Yaylaci S, Koroglu M, Uzun C, Karabay O. Effect of COVID-19 on platelet count and its indices. Rev Assoc Med Bras (1992). 2020 Aug; 66(8):1122-1127. PMID: 32935808.
      Citations: 8     Fields:    Translation:HumansCellsPHPublic Health
    22. Nalbant A, Kaya T, Varim C, Yaylaci S, Tamer A, Cinemre H. Can the neutrophil/lymphocyte ratio (NLR) have a role in the diagnosis of coronavirus 2019 disease (COVID-19)? Rev Assoc Med Bras (1992). 2020 Jun; 66(6):746-751. PMID: 32696861.
      Citations: 7     Fields:    Translation:HumansCellsPHPublic Health
    23. Dheir H, Sipahi S, Yaylaci S, Köroglu M, Erdem AF, Karabay O. Is there relationship between SARS-CoV-2 and the complement C3 and C4? Turk J Med Sci. 2020 06 23; 50(4):687-688. PMID: 32421281.
      Citations: 5     Fields:    Translation:Humans
    Yaylaci's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (108)
    Explore
    _
    Co-Authors (60)
    Explore
    _
    Similar People (60)
    Explore
    _